GABA Composition for Vagal Satiety Signaling and Binge Eating

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a challenge in managing excessive caloric intake and binge eating, which can lead to obesity and related health issues, as voluntary dietary restriction is difficult and often accompanied by a decrease in vitality and hunger-related discomfort.

Innovation Solution

A GABA-containing composition is developed to induce transient satiety and suppress binge eating by activating vagal afferent nerves, promoting GLP-1 secretion, and inhibiting GIP secretion, which can be administered alone or combined with energy-producing nutrients and dietary fibers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If voluntary dietary restriction is implemented to control caloric intake, then obesity and related health issues can be prevented, but vitality decreases and hunger-related discomfort increases

Engineering Contradiction:

Improveobesity and health disordersVSAvoiddifficulty of continuous dietary restriction

Core Design Contradiction:

Object-affected harmful factorsVSEase of operation

Solution Approach 1:

GABA acts as an intermediary substance that mediates between caloric restriction and satiety induction. The composition includes GABA (10-5000 mg/day) combined with vagal afferent nerve activators, which together produce satiety effects without requiring severe dietary restriction, thereby maintaining vitality while preventing obesity

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The composition enables the body's own satiety mechanisms to function properly by activating vagal afferent nerves and regulating gut hormones (GLP-1 and GIP). This self-regulating system naturally controls food intake and prevents binge eating without external forceful restriction

Inventive Principle:

Principle #25Self-service

2Loss of energy

If caloric intake is restricted to prevent obesity, then excessive calorie consumption is reduced, but the sense of hunger increases and interferes with daily life

Engineering Contradiction:

Improveexcessive caloric intakeVSAvoidhunger and decreased vitality

Core Design Contradiction:

Loss of energyVSObject-affected harmful factors

Solution Approach 1:

The composition utilizes feedback mechanisms by activating vagal afferent nerves that send signals to the brain about satiety status. GABA modulation combined with vagal activation creates a feedback loop that naturally regulates food intake and suppresses hunger sensations, allowing caloric restriction without hunger discomfort

Inventive Principle:

Principle #23Feedback

Solution Approach 2:

The composition changes the physiological parameters of satiety signaling by modulating GABA levels and activating vagal afferent nerves. This shifts the satiety threshold parameter, enabling individuals to feel satisfied with lower caloric intake without experiencing excessive hunger

Inventive Principle:

Principle #35Parameter changes

3Productivity

If GABA is administered to induce satiety, then food intake is reduced and binge eating is suppressed, but the mechanism of action requires activation of vagal afferent nerves and regulation of gut hormones

Engineering Contradiction:

Improvesatiety induction and binge eating suppressionVSAvoidcomplexity of physiological mechanism

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

GABA serves multiple functions simultaneously: it modulates neural activity, activates vagal afferent nerves, and regulates gut hormone secretion. This multi-functionality simplifies the overall approach by using a single substance that addresses multiple aspects of the satiety mechanism rather than requiring separate interventions for each physiological pathway

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively reduces food intake, prevents excessive calorie consumption, and enhances satiety, thereby addressing obesity and related health issues while being safe and easily incorporated into various foods.

Implementation Method 1

Methodology Applied

Scientific EffectVagal afferent nerve activation:

Implementation Method 2

A GABA-containing composition for promoting secretion of glucagon-like peptide-1 (GLP-1) in a subject.

Methodology Applied

Scientific EffectHormone secretion:

Implementation Method 3

A GABA-containing composition for suppressing secretion of glucose-dependent insulinotropic polypeptide (GIP) in a subject.

Methodology Applied

Scientific EffectHormone secretion inhibition:

Data Source

PatentUS20250221950A1GABA-containing composition

Publication Date: 2025.07.10 PHARMA FOODS INT CO LTD

AI summary

According to the present invention, a composition that induces the feeling of satiety or suppresses binge eating is provided.The present invention provides a GABA-containing composition for inducing transient satiety in a subject. The present invention also provides a GABA-containing composition for suppressing binge eating on a fasting condition in a subject.